OppenheimerFunds Inc. Sells 2,907 Shares of Stericycle Inc (SRCL)

OppenheimerFunds Inc. decreased its stake in Stericycle Inc (NASDAQ:SRCL) by 14.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,474 shares of the business services provider’s stock after selling 2,907 shares during the period. OppenheimerFunds Inc.’s holdings in Stericycle were worth $951,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the company. Iridian Asset Management LLC CT acquired a new stake in Stericycle during the first quarter worth approximately $168,624,000. BlackRock Inc. grew its stake in Stericycle by 40.9% during the fourth quarter. BlackRock Inc. now owns 7,616,828 shares of the business services provider’s stock worth $279,461,000 after purchasing an additional 2,210,880 shares during the period. Oregon Public Employees Retirement Fund grew its stake in Stericycle by 6,998.9% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 1,638,209 shares of the business services provider’s stock worth $45,000 after purchasing an additional 1,615,132 shares during the period. Clarkston Capital Partners LLC grew its stake in Stericycle by 58.2% during the fourth quarter. Clarkston Capital Partners LLC now owns 3,998,885 shares of the business services provider’s stock worth $146,719,000 after purchasing an additional 1,470,840 shares during the period. Finally, Norges Bank acquired a new stake in Stericycle during the fourth quarter worth approximately $41,704,000. 96.52% of the stock is owned by institutional investors.

Several equities research analysts recently commented on SRCL shares. Zacks Investment Research raised Stericycle from a “sell” rating to a “hold” rating in a research note on Wednesday, May 1st. ValuEngine raised Stericycle from a “strong sell” rating to a “sell” rating in a research note on Tuesday, March 5th. Robert W. Baird cut Stericycle from a “neutral” rating to an “underperform” rating and set a $44.00 target price for the company. in a research note on Wednesday, April 17th. BidaskClub raised Stericycle from a “sell” rating to a “hold” rating in a research note on Wednesday, February 13th. Finally, Goldman Sachs Group raised Stericycle from a “neutral” rating to a “buy” rating and set a $66.00 target price for the company in a research note on Friday, March 1st. Four research analysts have rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the stock. Stericycle has a consensus rating of “Hold” and a consensus price target of $59.00.

NASDAQ:SRCL traded up $0.40 on Friday, hitting $49.19. The stock had a trading volume of 107,957 shares, compared to its average volume of 1,426,020. The firm has a market cap of $4.44 billion, a P/E ratio of 11.05, a PEG ratio of 1.90 and a beta of 1.11. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.02 and a current ratio of 1.02. Stericycle Inc has a 52 week low of $34.36 and a 52 week high of $71.43.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings results on Thursday, February 28th. The business services provider reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.07. The business had revenue of $852.70 million for the quarter, compared to analyst estimates of $848.75 million. Stericycle had a positive return on equity of 12.56% and a negative net margin of 8.92%. On average, equities analysts forecast that Stericycle Inc will post 3.35 earnings per share for the current fiscal year.

In other Stericycle news, Director Mark C. Miller sold 260,314 shares of the stock in a transaction that occurred on Tuesday, April 9th. The stock was sold at an average price of $57.18, for a total value of $14,884,754.52. Following the transaction, the director now owns 325,848 shares in the company, valued at $18,631,988.64. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 2.30% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION NOTICE: “OppenheimerFunds Inc. Sells 2,907 Shares of Stericycle Inc (SRCL)” was posted by Modern Readers and is owned by of Modern Readers. If you are reading this article on another website, it was illegally copied and republished in violation of international trademark and copyright laws. The original version of this article can be read at https://www.modernreaders.com/news/2019/05/17/oppenheimerfunds-inc-sells-2907-shares-of-stericycle-inc-srcl.html.

Stericycle Profile

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.

Read More: What is the Ex-Dividend Date in Investing?

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.